Allegra-D, Fexofenadine/Pseudoephedrine Wire

Comprehensive News Feed for Allegra-D, Fexofenadine/Pseudoephedrine (generic).

Results 1 - 14 of 14 in Allegra-D, Fexofenadine/Pseudoephedrine (generic)

1. Teva Introduces Fexofenadine HCl and Pseudoephedrine HCl...

   Tuesday Nov 3 | BusinessWire

   Teva Pharmaceutical Industries Ltd. announced today the commercial launch of Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, the same as the sanofi-aventis U.S. allergy treatment Allegra-D 12 Hour Extended-Release Tablets.

   Comment?

   Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, SanofiSynthlabo, Allergy, Health, Medication, Marketing

2. Prasco to aid sales of generic Allegra D

   Tuesday Nov 3 | The Cincinnati Enquirer

   Generic drug supplier Prasco Laboratories said Monday it will provide sales support and distribution services for generic versions of Allegra D 12-hour extended release tablets and Drisdol capsules in the United States under agreements with Winthrop, a U.S. unit of French-based Sanofi-Aventis. Privately held Prasco didn't release financial terms ...

   Comment?

   Related Topix: Medicine, Medication, Biotech, SanofiSynthlabo

3. Prasco, Winthrop ink distribution deal

   Monday Nov 2 | Cincinnati Business Courier

   Prasco Laboratories said Monday it has signed sales and distribution agreements with Winthrop U.S., a unit of Sanofi-Aventis U.S. Under the agreements, Prasco will distribute and provide sales support for authorized generic versions of Allegra-D 12-hour extended release tablets, and Drisdol capsules under the Winthrop label.

   Comment?

   Related Topix: Biotech, SanofiSynthlabo, Medicine, Bridgewater, NJ

4. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide...

   Monday Nov 2 | Pharmaceutical Processing

   Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S. Prasco Laboratories announced today that it has entered into agreements with Winthrop U.S., a business of sanofi-aventis U.S., to provide sales support and distribution services ...

   Comment?

   Related Topix: Biotech, SanofiSynthlabo

5. Icon_question

   Saturday Oct 17 | HealthCentral

   Are you an asthma sufferer? Manage your asthma or COPD with great ideas from people like you.

   Comment?

   Related Topix: Allegra, Fexofenadine (generic), Medicine, Medication, Allergy, Health

6. AMRI Files New Patent Infringement Lawsuits against Dr. Reddya s Laboratories and Sandoz

   Sep 15, 2009 | Business Wire

   AMRI announced today that it has filed two new patent infringement lawsuits in U.S. District Court in New Jersey against Dr.

   Comment?

   Related Topix: Biotech, Albany Molecular Research, Medicine, Healthcare Industry, Dr Reddys Laboratories, Allegra, Fexofenadine (generic), Medication, SanofiSynthlabo

7. Sanofi-Aventis plans to close Kansas City plant

   Aug 28, 2009 | Clover Herald

   Drug developer Sanofi-Aventis says it will close its Kansas City, Mo., plant by 2012, citing a decline in demand for products made at the site.

   Comment?

   Related Topix: Biotech, SanofiSynthlabo, Kansas City, MO, Medicine, Allergy, Health, Medication

8. Sanofi-Aventis plans to close Kansas City plant

   Aug 28, 2009 | Salon.com

   Drug developer Sanofi-Aventis says it will close its Kansas City, Mo., plant by 2012, citing a decline in demand for products made at the site.

   Comment?

   Related Topix: Biotech, SanofiSynthlabo, Kansas City, MO, Medicine, Allergy, Health, Medication

9. Sanofi-aventis to close Kansas City plant

   Aug 28, 2009 | St. Louis Business Journal

   Sanofi-aventis , which has St. Louis operations, said Thursday that it will close its Kansas City manufacturing facility.

   Comment?

   Related Topix: Kansas City, MO, Biotech, SanofiSynthlabo, St Louis County, MO, Creve Coeur, MO, Medicine, Allergy, Health

10. Sanofi-Aventis Plans to Close Kansas City Plant

    Aug 28, 2009 | WDAF

    Drug developer Sanofi-Aventis says it will close its Kansas City, Mo., plant by 2012, citing a decline in demand for products made at the site.

    Comment?

    Related Topix: Biotech, SanofiSynthlabo, Kansas City, MO, Medicine, Allergy, Health

11. Drug developer to close KC plant

    Aug 28, 2009 | The Capital-Journal

    Drug developer Sanofi-Aventis says it will close its Kansas City, Mo., plant by 2012, citing a decline in demand for products made at the site.

    Comment?

    Related Topix: Biotech, SanofiSynthlabo, Medicine, Allergy, Health, Medication

12. Sanofi-aventis will close KC plant, cut about 370 jobs

    Aug 24, 2009 | Kansas City Business Journal

    Sanofi-aventis said Thursday that it will close its Kansas City manufacturing facility.

    Comment?

    Related Topix: Biotech, SanofiSynthlabo, Kansas City, MO

13. My Chronic Cough Turned Out to Be Asthma w/Photo

    Aug 9, 2009 | Health

    Laura Finlayson, 38, from Westwood, N.J., just couldna t seem to shake her persistent cough.

    Comment?

    Related Topix: Medicine, Asthma, Westwood, NJ

14. allegra d generic

    Jul 23, 2009 | Almost Cool

    Good seg narcotic rate quality necessary to those of allegra d generic raleigh newark. 1 comment

    Related Topix: Medicine